publication . Article . 2013

Utilización de la hormona de crecimiento en niños y adolescentes

Ignacio Bergadá;
Open Access English
  • Published: 01 Jun 2013 Journal: Medicina (Buenos Aires) (issn: 1669-9106, Copyright policy)
  • Publisher: Fundación Revista Medicina
Abstract
El uso de la hormona de crecimiento en niños y adolescentes lleva más de cinco décadas. Desde el año 1985 se utiliza solamente hormona de crecimiento humana recombinante (rhGH). En la mayoría de los países el tratamiento con rhGH está indicado para el tratamiento de niños y adolescentes con deficiencia de hormona de crecimiento, síndrome de Turner, síndrome de Prader-Willi, insuficiencia renal crónica y niños nacidos pequeños para edad gestacional. El objetivo del tratamiento es mejorar el crecimiento de los pacientes. La eficacia del tratamiento evaluada en parámetros auxológicos demuestra que la respuesta es variable de acuerdo a cada indicación en particular....
Subjects
free text keywords: Hormona de crecimiento, rhGH, Medicine, R, Immunologic diseases. Allergy, RC581-607, Infectious and parasitic diseases, RC109-216
Download from

1. Raben MS. Treatment of a pituitary dwarf with human growth hormone. J Clin Endocrinol Metab 1958; 18: 901-3.

2. National Hormone and Pituitary Program (NHPP): Information for People Treated with Human Growth Hormone. En: http://endocrine.niddk.nih.gov/pubs/creutz/updatecomp. aspx

3. Kaplan SL, Underwood LE, August GP, et al. Clinical studies with recombinant-DNA-derived methionyl human growth hormone in growth hormone deficient children. Lancet 1986; 1: 697-700.

4. Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary state - ment of the GH Research Society. GH Research Society. J Clin Endocrinol Metab 2000; 85: 3990-3.

5. Reiter EO, Price DA, Wilton P, Albertsson-Wikland K, Ranke MB. Effect of growth hormone (GH) treatment on the near-final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database. J Clin Endocrinol Metab 2006; 91: 2047-54. [OpenAIRE]

6. Baxter L, Bryant J, Cave CB, Milne R. Recombinant growth hormone for children and adolescents with Turner syndrome. Cochrane Database Syst Rev 2007; CD003887.

7. Rosenfeld RG, Attie KM, Frane J, et al. Growth hormone therapy of Turner's syndrome: beneficial effect on adult height. J Pediatrics 1998; 132: 319-24.

8. Sas T, de Muinck Keizer-Schrama S, Aanstoot HJ, Stij - nen T, Drop S. Carbohydrate metabolism during growth 14. Deodati A, Peschiaroli E, Cianfarani S. Review of growth hormone treatment and after discontinuation of growth hormone randomized controlled trials in children with idihormone treatment in girls with Turner syndrome treated opathic short stature. Horm Res Paediatr 2011; 76 Suppl with once or twice daily growth hormone injections. Clin 3: 40-2. Endocrinol (Oxf) 2000; 52: 741-7. 15. FDA talk paper 2003 FDA approves Humatrope for short

9. de Lind van Wijngaarden RF, Siemensma EP, Festen DA, stature [US FDA Web Site]. En: http://www.fda.gov/bbs/ et al. Efficacy and safety of long-term continuous growth topics/ANSWERS/2003/ANS01242.html hormone treatment in children with Prader-Willi Syndro- 16. Wilton P. Adverse events reported in KIGS. In: Ranke MB, me. J Clin Endocrinol Metab 2009; 94: 4205-15. Price DA, Reiter EO, eds. Growth hormone therapy in Pae-

10. Haffner D, Schaefer F, Nissel R, Wühl E, Tönshoff B, Me- diatrics, 20 years of KIGS. Basel: Karger, 2007, p 432-41. hls O. Effect of growth hormone treatment on the adult 17. Burgers AMG, Biermasz NR, Schoones JW, et al. Metaheight of children with chronic renal failure. German Study analysis and dose-response metaregression: circulating Group of Growth Hormone Treatment in Chronic Renal insulin-like growth factor I (IGF-I) and mortality. J Clin Failure. N Engl J Med 2000; 343: 923-30. Endocrinol Metab 2011; 96: 2912-20.

11. Boguszewski MC, Mericq V, Bergada I, et al. Latin Ameri- 18. Carel JC, Ecosse E, Landier F, et al. Long-term mortality can consensus: children born small for gestational age. after recombinant growth hormone treatment for isolated BMC Pediatr 2011; 11: 66. growth hormone deficiency or childhood short stature:

12. de Zegher F, Ong K, van Helvoirt M, Mohn A, Woods preliminary report of the French SAGhE Study. J Clin K, Dunger D. High dose growth hormone treatment in Endocrinol Metab 2012; 97: 416-25. non-GH-deficient children born small for gestational age 19. Malozowski S. Reports of increased mortality and GH: induces growth responses related to pretreatment GH will this affect current clinical practice? J Clin Endocrinol secretion and associated with a reversible decrease in Metab 2012; 97: 380-3. insulin sensitivity. J Clin Endocrinol Metab 2002; 87: 20. Sävendahl L, Maes M, Albertsson-Wikland K, et al. Long148-51. term mortality and causes of death in isolated GHD, ISS,

13. Bergadá I, Blanco M, Keselman A, Domené HM, Bergadá and SGA patients treated with recombinant growth horC. Tratamiento con hormona de crecimiento en niños mone during childhood in Belgium, The Netherlands, and menores de 6 años de edad, con talla baja, nacidos Sweden: preliminary report of 3 countries participating in pequeños para la edad gestacional. Arch Argent Pediatr the EU SAGhE study. J Clin Endocrinol Metab 2012; 97: 2009; 107: 410-6. E213-7.

Any information missing or wrong?Report an Issue